Sinopharm vaccine approval subject to certain conditions: SAHPRA - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

📆 2022-02-08 오후 11:01:00
📰 SABCNews

⏱ Reading Time:
33 sec. here
2 min. at publisher
📊 Quality Score:
News: 17%
Publisher: 51%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The South African Health Products Regulatory Authority has reiterated that the authorisation of the Sinopharm vaccine is subject to a number of conditions, including that the jab is supplied in accordance with the national COVID-19 vaccination programme.

Signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services , following the COVID-19 outbreak, in Beijing, China September 5, 2020.is subject to a number of conditions.

The Chinese-made two-dose vaccine was registered at the end of last month and deemed fit for use on adults aged 18 years and older.The regulator’s CEO Dr Boitumelo Semete says, “We still have to look at the safety of the vaccine and also look at the quality of it, is the facility where it was manufactured compliant with standards, etc.”

In May last year, the World Health Organisation approved the Sinopharm vaccine for COVID-19 emergencies.As of 07 February 2022, a total of 30 255 366 COVID-19 vaccines had been administered. People who received the second dose of their Pfizer jab at least six months ago can now get their booster shot.

댓글 쓰기

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

South Africa needs to a pick a Covid strategy and stick to it: finance bossEY Africa chief executive Ajen Sita says South Africa needs to ‘radically and rapidly’ get its economy working again, with the country facing a number of challenges that need urgent government attention. just let people do what they want, that’s the best strategy
출처: BusinessTechSA - 🏆 24. / 61 더 많은 것을 읽으십시오 »